Italy agency cautious on AstraZeneca jab for over 55s
Adding ipilimumab to pembrolizumab does not improve efficacy in patients with NSCLC
30 January 2021Novavax COVID-19 vaccine news welcomed in South Africa
30 January 2021Italy agency cautious on AstraZeneca jab for over 55s
Italy’s medicines agency on Saturday approved the AstraZeneca coronavirus vaccine for all adults but recommended alternatives be given to people aged over 55.
